Company Filing History:
Years Active: 2002
Title: Inventor Wang Jiang-Yang: Innovating in Genetic Research
Introduction
Wang Jiang-Yang is a notable inventor based in San Diego, California. He has made significant contributions to the field of genetic research, particularly through his innovative work on nucleic acid encoding. His insights have the potential to impact various physiological studies and therapeutic applications.
Latest Patents
Wang Jiang-Yang holds a patent for his invention related to nucleic acid encoding human potassium channel K⁺ nov1 protein. This patent, which provides methods for isolating K⁺Hnov genes, plays a crucial role in identifying homologous or related proteins and the DNA sequences that encode them. The compositions derived from this work are valuable for producing substances that can modulate the expression or function of the protein involved. Furthermore, his research aids in exploring associated physiological pathways. The modulation of gene activity, as outlined in his patent, has therapeutic implications, such as identifying cell types based on expression.
Career Highlights
Currently, Wang Jiang-Yang is employed at Icagen, Inc., a company known for its focus on innovative drug development and research in the life sciences. His work contributes to advancing the understanding of complex biological systems and developing potential treatments for various conditions.
Collaborations
Within Icagen, Wang collaborates with several talented peers, including Andrew Miller and Ping Hu. These collaborations foster a dynamic environment where innovation thrives, allowing the team to combine their expertise to push the boundaries of genetic research.
Conclusion
Wang Jiang-Yang exemplifies the spirit of innovation in the field of genetics. His patent on nucleic acid encoding human potassium channel K⁺ nov1 protein showcases his commitment to advancing scientific knowledge and therapeutic capabilities. As he continues his work at Icagen, his contributions are likely to inspire further advancements in medical research and technologies.